- Home
- ELTK vs HOWL Comparison
ELTK vs HOWL Comparison
Compare ELTK & HOWL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELTK
- HOWL
- Stock Information
- Founded
- ELTK 1970
- HOWL 2017
- Country
- ELTK Israel
- HOWL United States
- Employees
- ELTK N/A
- HOWL N/A
- Industry
- ELTK Electrical Products
- HOWL Biotechnology: Pharmaceutical Preparations
- Sector
- ELTK Technology
- HOWL Health Care
- Exchange
- ELTK Nasdaq
- HOWL Nasdaq
- Market Cap
- ELTK 73.9M
- HOWL 87.4M
- IPO Year
- ELTK 1997
- HOWL 2021
- Fundamental
- Price
- ELTK $11.40
- HOWL $1.38
- Analyst Decision
- ELTK
- HOWL Strong Buy
- Analyst Count
- ELTK 0
- HOWL 2
- Target Price
- ELTK N/A
- HOWL $9.50
- AVG Volume (30 Days)
- ELTK 13.1K
- HOWL 286.2K
- Earning Date
- ELTK 03-10-2025
- HOWL 03-06-2025
- Dividend Yield
- ELTK 1.92%
- HOWL N/A
- EPS Growth
- ELTK N/A
- HOWL N/A
- EPS
- ELTK 0.85
- HOWL N/A
- Revenue
- ELTK $48,090,000.00
- HOWL $3,386,000.00
- Revenue This Year
- ELTK $7.47
- HOWL N/A
- Revenue Next Year
- ELTK $9.96
- HOWL $34.17
- P/E Ratio
- ELTK $13.23
- HOWL N/A
- Revenue Growth
- ELTK 7.22
- HOWL N/A
- 52 Week Low
- ELTK $9.00
- HOWL $1.31
- 52 Week High
- ELTK $22.80
- HOWL $8.19
- Technical
- Relative Strength Index (RSI)
- ELTK 56.29
- HOWL 39.98
- Support Level
- ELTK $10.86
- HOWL $1.31
- Resistance Level
- ELTK $11.35
- HOWL $1.72
- Average True Range (ATR)
- ELTK 0.32
- HOWL 0.10
- MACD
- ELTK 0.03
- HOWL 0.01
- Stochastic Oscillator
- ELTK 90.67
- HOWL 17.07
About ELTK Eltek Ltd.
Eltek Ltd is engaged in the technology business sector that manufactures and supplies technologically new custom-made circuitry solutions. It manufactures, markets, and sells custom-made printed circuit boards (PCBs), including high-density interconnects. The Company markets its products mainly to the medical technology, defense and aerospace, industrial, telecom, and networking equipment industries. Its geographic areas are Israel, North America, the Netherlands, India, and Others. It generates the majority of its revenue from Israel.
About HOWL Werewolf Therapeutics Inc.
Werewolf Therapeutics Inc is a biopharmaceutical company pioneering the development of therapeutics engineered to stimulate the body's immune system for the treatment of cancer. It is leveraging its proprietary PREDATOR platform to design conditionally activated molecules that stimulate both adaptive and innate immunity with the goal of addressing the limitations of conventional proinflammatory immune therapies. Its INDUKINE molecules are intended to remain inactive in peripheral tissue yet activate selectively in the tumor microenvironment or TME.